Evidence map›Paper›PMID 30571679›Full record

ArticlePloS one2018

GI-16 lineage (624/I or Q1), there and back again: The history of one of the major threats for poultry farming of our era.

Giovanni Franzo, Mattia Cecchinato, Giovanni Tosi, Laura Fiorentini, Francesca Faccin, Claudia Maria Tucciarone, Tiziana Trogu, Ilaria Barbieri, Paola Massi, Ana Moreno

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Molecular epidemiology of infectious bronchitis virus in Poland from 1980 to 2017.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2020
    Article
  19. Article
  20. A Shift inAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Giovanni FranzoDepartment of Animal Medicine, Production and Health (MAPS), University of Padua, Legnaro (PD), Italy.
Mattia CecchinatoDepartment of Animal Medicine, Production and Health (MAPS), University of Padua, Legnaro (PD), Italy.
Giovanni TosiSezione di Forlì, Istituto Zooprofilattico Sperimentale della Lombardia e Emilia Romagna, Forlì Cesena, Italy.
Laura FiorentiniSezione di Forlì, Istituto Zooprofilattico Sperimentale della Lombardia e Emilia Romagna, Forlì Cesena, Italy.
Francesca FaccinDepartment of Virology, Istituto Zooprofilattico Sperimentale della Lombardia e Emilia Romagna, Brescia, Italy.
Claudia Maria TucciaroneDepartment of Animal Medicine, Production and Health (MAPS), University of Padua, Legnaro (PD), Italy.ORCID 0000-0002-0340-8920
Tiziana TroguDepartment of Virology, Istituto Zooprofilattico Sperimentale della Lombardia e Emilia Romagna, Brescia, Italy.
Ilaria BarbieriDepartment of Virology, Istituto Zooprofilattico Sperimentale della Lombardia e Emilia Romagna, Brescia, Italy.
Paola MassiSezione di Forlì, Istituto Zooprofilattico Sperimentale della Lombardia e Emilia Romagna, Forlì Cesena, Italy.
Ana MorenoDepartment of Virology, Istituto Zooprofilattico Sperimentale della Lombardia e Emilia Romagna, Brescia, Italy.ORCID 0000-0002-8497-9708

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genetic variability of Infectious bronchitis virus (IBV) is one of the main challenges for its control, hindering not only the development of effective vaccination strategies but also its classification and, consequently, epidemiology understanding. The 624/I and Q1 genotypes, now recognized to be part of the GI-16 lineage, represent an excellent example of the practical consequences of IBV molecular epidemiology limited knowledge. In fact, being their common origin unrecognized for a long time, independent epidemiological pictures were drawn for the two genotypes. To fix this misinterpretation, the present study reconstructs the history, population dynamics and spreading patterns of GI-16 lineage as a whole using a phylodynamic approach. A collection of worldwide available hypervariable region 1 and 2 (HVR12) and 3 (HVR3) sequences of the S1 protein was analysed together with 258 HVR3 sequences obtained from samples collected in Italy (the country where this genotype was initially identified) since 1963. The results demonstrate that after its emergence at the beginning of the XX century, GI-16 was able to persist until present days in Italy. Approximately in the late 1980s, it migrated to Asia, which became the main nucleus for further spreading to Middle East, Europe and especially South America, likely through multiple introduction events. A remarkable among-country diffusion was also demonstrated in Asia and South America. Interestingly, although most of the recent Italian GI-16 strains originated from ancestral viruses detected in the same country, a couple were closely related to Chinese ones, supporting a backward viral flow from China to Italy. Besides to the specific case-study results, this work highlights the misconceptions that originate from the lack of a unified nomenclature and poor molecular epidemiology data generation and sharing. This shortcoming appears particularly relevant since the described scenario could likely be shared by many other IBV genotypes and pathogens in general.

Indexed as

GenotypeAnimalsChickensCoronavirus InfectionsInfectious bronchitis virusPoultry Diseases

Identifiers

PMID30571679
PMCPMC6301571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.